Resources

The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for salmonella.

A summary of the major items discussed at the fifth MDAF meeting.

A framework to prevent and reduce alcohol-related harm. It highlights possible actions at the local, state or territory and national levels.

This framework sets a nationally consistent quality benchmark for providers of drug and alcohol treatment services. It includes strong clinical governance requirements and a list of accreditation standards that drug and alcohol specialist treatment service providers must meet.

This report contains the recommendations the Specialist and Consultant Physician Consultation Clinical Committee made to the MBS Review Taskforce, after public consultation.

This report shows the monthly growth in ACFI subsidies compared to estimates for December 2019.

This departmental review looked at the effectiveness of the National Prescribing Service, NPS MedicineWise, in delivering the Quality Use of Medicines Program.

This document provides key statistics from the 2018–19 report on the operation of the Aged Care Act 1997 (ROACA). It includes statistics for different types of care, the aged care workforce and quality and regulation.

These infographics highlight the key facts of the 2018–19 report on the operation of the Aged Care Act 1997 (ROACA). They include statistics on aged care providers, expenditure and types of aged care services.

This document outlines the Prime Minister's National Suicide Prevention Adviser's initial advice and early findings.

This communique summarises the third meeting of the National Dust Disease Taskforce, held on 29 November 2019.

These terms of reference outline the functions and responsibilities of the Marketing in Australia of Infant Formula (MAIF) Complaints Committee. The committee reviews complaints made against members of the MAIF Agreement.

Service providers under the National Aboriginal and Torres Strait Islander Flexible Aged Care Program must follow exit requirements when reducing or ending their aged care services.

A summary of how service providers can apply for funding under the National Aboriginal and Torres Strait Islander Flexible Aged Care Program.

This report details the operation of Australia’s aged care system during the 2018–19 financial year. It is the twenty-first report in the series. The report is delivered to Parliament by the Minister in accordance with section 63-2 of the Aged Care Act 1997 (the Act).

This communique summarises the meeting of the Residential Aged Care (RAC) Funding Reform Working Group held on 27 November 2019.

The Australian Public Service (APS) employee census is conducted from May and June each year. It collects information on attitudes and opinions of APS employees. This report presents results for the Department of Health.

This fact sheet provides step-by-step instructions on how to find the location and need multipliers for a clinic.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 6 variants of the current listing of the Ainscorp Salts Confidence from subgroup 2(b) of the Stoma Appliance Scheme Schedule, due to low demand.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 3 variants that have been superseded from the current listing of the Ainsworth Salts Harmony Duo in subgroup 4(d) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 3 variants from the current listing of the Ainscorp Salts Confidence in subgroup 1(c) of the Stoma Appliance Scheme Schedule, due to low demand.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 5 variants that have been superseded from the current listing of the Ainscorp Salts Harmony Duo in subgroup 4(d) of the Stoma Appliance Scheme Schedule.

This public summary document outlines a Stoma Product Assessment Panel (SPAP) recommendation to delete 1 variant that is no longer manufactured from the current listing of the Omnigon Pelican in subgroup 2(a) of the Stoma Appliance Scheme Schedule.

This document provides the results of an independent review of the Pharmacy Trial Program.

This statement explains why the BreastScreen Australia program uses mammography rather than thermography to detect breast cancer.